Skip to main content

Table 3 Hemodynamic data

From: Pulmonary hypertension in systemic sclerosis: diagnosis by systematic screening and prognosis after three years follow-up

 

No-RHC-PH (n = 5)

SSc-ILD-PH (n = 2)

SSc-PH Group 2

SSc-PAH (n = 11)

SSc-PAH# (Bo-PAH) (n = 5)

P value (ANOVA)

mPAP mmHg (SD)

18 (2.00)

48.5 (28.99)

33.0 (4.24)

32.8 (13.31)

22.6 (1.34)

0.03 (F = 3.32)

PAWP mmHg (SD)

11.6 (5.12)

13.5 (2.51)

15.5 (9.19)

13.4 (2.94)

13.2 (3.70)

0.80 (F = 0.41)

PVRi WU (SD)

2.05 (1.04)

34.3 (24.47)

3.11 (0)

6.03 (4.73)

2.66 (0.91)

0.003 (F = 9.26)

RA mmHg (SD)

2.6 (1.51)

8.5 (2.12)

9.0 (0)

10.6 (8.26)

5.4 (1.14)

0.18 (F = 1.72)

TGP mmHg (SD)

6.4 (5.22)

33.0 (19.79)

14.0 (2.82)

27.83 (12.23)

9.4 (3.43)

0.004 (F = 5.990)

  1. mPAP mean pulmonary arterial pressure, PVRi peripheral vascular resistance index, PAWP pulmonary capillary wedge pressure, RA right atrium, SD standard deviation, WU Woods unit, TGP transpulmonary pressure gradient
  2. Obs.: # subgroup of all patients with SSc PAH and mPAP > 20 mmHg—< 25 mmHg, lately named bordeline (Bo-PAH)